Evacetrapib (LY2484595) (LY2484595) is a potent and selective inhibitor of CETP with IC50 of 5.5 nM, elevates HDL cholesterol without increases in aldosterone or blood pressure. Phase 3.
Molecular Weight:
638.65
Purity:
98.53%
CAS Number:
[1186486-62-3]
Formula:
C31H36F6N6O2
Target:
CETP
T6262
* VAT and and shipping costs not included. Errors and price changes excepted